A novel microRNA promotes coxsackievirus B4 infection of pancreatic β cells
2024

A novel microRNA promotes coxsackievirus B4 infection of pancreatic β cells

Sample size: 3 publication Evidence: moderate

Author Information

Author(s): Lalani Salima, Knudsen Joseph, Kenney James, Hober Didier, DiPersio C. Michael, Gerber Allen

Primary Institution: Albany Medical College

Hypothesis

Coxsackievirus B alters the miRNA signature of pancreatic β cells, contributing to the autoimmune response that triggers type 1 diabetes.

Conclusion

Inhibiting the microRNA hsa-miR-AMC1 reduces coxsackievirus B4 infection and may increase insulin production in pancreatic β cells.

Supporting Evidence

  • Treatment with an antagomir targeting hsa-miR-AMC1 led to decreased coxsackievirus B4 infection in pancreatic β cells.
  • Hsa-miR-AMC1 was upregulated in pancreatic β cells following coxsackievirus B4 infection.
  • Inhibition of hsa-miR-AMC1 was associated with increased insulin production in infected β cells.

Takeaway

A new microRNA helps a virus infect cells that produce insulin, and stopping this microRNA might help people with diabetes.

Methodology

The study used small RNA-sequencing and qPCR to analyze the effects of coxsackievirus B4 on pancreatic β cells and the role of hsa-miR-AMC1.

Statistical Information

P-Value

1.89E-05

Statistical Significance

p<0.0001

Digital Object Identifier (DOI)

10.3389/fimmu.2024.1414894

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication